Consistent with this data, we observed the elevated FGF-2 levels in serum of IM-resistant GIST xenografts treated with IM when compared to non-treated mice bearing IM-resistant GISTs (Figure 6E). The gene discussed is FGF2; the disease is gastrointestinal stromal tumor.